15 Jul Applications Sought to Access Biospecimens to Advance Research on Heart Disease & Diabetes
The Indiana Clinical and Translational Science Institute is calling for applications from CTSA investigators to access biospecimens to advance research on coronary artery disease and type 2 diabetes.
Specimens are available from Fairbanks Institute for Healthy Communities, a non-profit organization that operates INbank, which contains biological samples are linked with longitudinal clinical and disease-specific health records information from the Indiana Network for Patient Care (INPC), a state-wide electronic clinical data repository.
The INPC link enables the Fairbanks Institute to connect bio-specimens drawn at a point in time or over time with active patient medical record information, creating a longitudinal view of the subjects disease progression, interventions and outcomes. Fairbanks Institutes collection consists of samples from two disease based study collections which are the coronary artery disease (CAD) collection and the type II diabetes (T2D) collection.
Applications are due 5 p.m. Friday, Aug. 15. Samples will be provided free of charge to qualified investigators. This application is designed to promote research studies using the Fairbanks Institute’s samples. Only bio-specimen will be made available. Requests for other resources are not permissible.
Submissions must include a current maximum four-page NIH biosketch. For complete application guidelines and materials, visit the Indiana CTSI’s grants portal and enter your institutional username and password. (CTSA members whose institutions are not listed may create a guest account with the Indiana CTSI using the instructions to the right of the login screen.) Applications instructions are located under “Fairbanks Institute: Biological Samples with Longitudinal EHR Data for Research – 2014.08 (FIB).”97 kBFairbanks Institute Request for Applications for Samples 07.01.14 16 kBIndianaCTSI-FairbanksInstitute-BiospecimensAccessRFA